Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: VITALANT
Awarding agency: Department of Health and Human Services / Centers for Disease Control and Prevention
Funding agency: Department of Health and Human Services / Centers for Disease Control and Prevention
Period of performance: 2020-05-12 to 2024-05-11
Current total value of award: $46437074
Description: CHARACTERIZE SEROPREVALENCE OF SARS COV-2 ANTIBODIES IN THE US POPULATION